Project Grant RF1MH138582
- The National Institute of Mental Health awarded Indiana University $853,969 on September 24, 2025, under the Mental Health Research Grants program (CFDA 93.242) to investigate maternal depression trajectories across 25 years in low-income families participating in a randomized parenting intervention trial. The project analyzes longitudinal data from 731 low-income families enrolled in the Early Steps Multisite (ESM) study, assessed 13 times from child ages 2 to 19. Investigators will identify...
- The National Institute of Mental Health awarded Indiana University Indianapolis $667,598 on September 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct a pilot randomized controlled trial evaluating CAMS-4TEENS, an evidence-based suicide-specific treatment adapted for adolescents involved in the juvenile justice system. The award funds two primary research aims. Aim 1 establishes the feasibility and acceptability of a pilot RCT comparing CAMS-4TEENS to enhanced...
- The National Institute of Mental Health awarded the President and Fellows of Harvard College, through its Harvard T.H. Chan School of Public Health division, $418,000 on August 10, 2026, to identify epigenetic biomarkers that predict the risk and progression of depression among young adolescents under the Mental Health Research Grants program (CFDA 93.242). The recipient will investigate how DNA methylation and microRNA expression mediate the effects of early life stress on adolescent...
- The National Institute of Mental Health awarded Indiana University Indianapolis $1.632 million on August 12, 2026, under the Mental Health Research Grants program (CFDA 93.242) to establish and operate Academic-Community EPINET, a learning healthcare system network designed to enhance outcomes in early psychosis care through improved stress tolerance and continuous quality improvement. The award funds a network of six early intervention clinical spoke sites connected through advanced informatics...
- The National Institute of Mental Health awarded Northwestern University $714,760 on July 21, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct a neuroimaging ancillary study investigating dopaminergic mechanisms of depression and antidepressant response in persons with HIV. The study will enroll 48 participants from a larger clinical trial comparing pramipexole (a dopamine agonist) against escitalopram (an SSRI) for antidepressant efficacy in major depressive...
- Federal Grant Award Summary Indiana University received a $420,519 Project Grant from the National Institute of Mental Health under the Mental Health Research Grants program (CFDA 93.242) effective May 15, 2025 through May 14, 2027. The award funds research into Temporal Interference (TI) electrical neurostimulation as a non-invasive deep brain stimulation technology. The project will deliver two primary research products: (1) characterization of TI's effects on blood oxygen level-dependent...
- The National Institute of Mental Health awarded the University of Connecticut Health Center $840,674 on August 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct a comprehensive study examining the independent effect of depression on financial capacity in older adults. The research tests a conceptual framework—the Mood, Motivation and Social Cognition Model of Diminished Financial Capacity in Late-Life Depression—to identify how specific behavioral features of...
- The National Institute of Mental Health awarded Trustees of Indiana University $831,656 on May 18, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop statistical models that associate brain connectivity patterns with human health outcomes using simplicial complex structures. The award funds the creation of advanced statistical methods to quantify not only pairwise co-activation of brain regions but also three-way and higher-order interactions through the...
- The National Institute of Mental Health awarded Northwestern University $188,499 under the Mental Health Research Grants program (CFDA 93.242) on July 24, 2026, to adapt digital single-session interventions for delivery by lay providers in rural high schools. The project focuses on addressing barriers to mental health care for adolescents with depression in rural communities, where internalizing problems are more prevalent yet mental health providers and treatment options are scarce. The...
- The National Institute of Mental Health awarded $466,175 to Massachusetts General Hospital on August 11, 2026, under the Mental Health Research Grants program (CFDA 93.242) to map neuroimmune circuitry implicated in major depressive disorder and treatment-resistant depression. The recipient will conduct multimodal neuroimaging and anatomical research to elucidate circuits connecting limbic regions with the nucleus tractus solitarii in the brainstem, a neural pathway through which inflammatory...
The National Institute of Mental Health awarded Trustees of Indiana University $2.938 million on September 24, 2025, under the Mental Health Research Grants program (CFDA 93.242) to investigate maternal depression trajectories across 25 years in relation to sociocultural risk factors and a randomized parenting intervention. The recipient will examine variation in depression trajectories among low-income mothers across two decades, prospectively analyzing how sociodevelopmental characteristics, child developmental periods, and contextual factors—including neighborhood conditions, social stress, financial strain, family support, individual identity, housing stability, and neighborhood support—relate to depressive symptom patterns. The study leverages the Early Steps Multisite Study, a longitudinal experimental cohort of 731 low-income families assessed 13 times from child ages 2 to 19, with families randomly assigned at baseline to receive the Family Check-Up intervention or a control condition. The research will evaluate whether the Family Check-Up buffers severity in maternal depression trajectories. Maternal depression, child and family functioning, and contextual factors have been prospectively assessed for nearly two decades; families were assessed nearly annually for eight years post-baseline, with intervention families offered the Family Check-Up. The work is performed in Bloomington, Indiana, with a period of performance through July 31, 2030. This is a Project Grant, the assistance type supporting discrete research projects within a specified funding period.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $2.9m | 8/12/26 |